SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS

SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS

The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: GECZY, Jozsef-Michel
Format: Patent
Sprache:eng ; hun
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GECZY, Jozsef-Michel
description The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or reducing the development of atherosclerosis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE029199TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE029199TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE029199TT23</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHvxIOof1gcUtJ5yDOnWLCZZyW7PpZR4Ei3U_6OCD_Ayc5hZVxfpRS0lbOuMAa0gcLYBIgehluOngON4ZSElTtBxBs1oldIZrHrMLC58SbKtVrfxvpTdz5tq36E6X5f5OZRlHqfyKK_B93hozNEY1eb0z_MG6_MvAQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS</title><source>esp@cenet</source><creator>GECZY, Jozsef-Michel</creator><creatorcontrib>GECZY, Jozsef-Michel</creatorcontrib><description>The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or reducing the development of atherosclerosis.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170328&amp;DB=EPODOC&amp;CC=HU&amp;NR=E029199T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170328&amp;DB=EPODOC&amp;CC=HU&amp;NR=E029199T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GECZY, Jozsef-Michel</creatorcontrib><title>SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS</title><description>The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or reducing the development of atherosclerosis.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHvxIOof1gcUtJ5yDOnWLCZZyW7PpZR4Ei3U_6OCD_Ayc5hZVxfpRS0lbOuMAa0gcLYBIgehluOngON4ZSElTtBxBs1oldIZrHrMLC58SbKtVrfxvpTdz5tq36E6X5f5OZRlHqfyKK_B93hozNEY1eb0z_MG6_MvAQ</recordid><startdate>20170328</startdate><enddate>20170328</enddate><creator>GECZY, Jozsef-Michel</creator><scope>EVB</scope></search><sort><creationdate>20170328</creationdate><title>SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS</title><author>GECZY, Jozsef-Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE029199TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GECZY, Jozsef-Michel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GECZY, Jozsef-Michel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS</title><date>2017-03-28</date><risdate>2017</risdate><abstract>The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or reducing the development of atherosclerosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; hun
recordid cdi_epo_espacenet_HUE029199TT2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GECZY,%20Jozsef-Michel&rft.date=2017-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE029199TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true